CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+51.74%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$645M
AUM Growth
+$645M
Cap. Flow
+$46.7M
Cap. Flow %
7.24%
Top 10 Hldgs %
48.69%
Holding
75
New
11
Increased
16
Reduced
10
Closed
6
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
NGNE icon
51
Neurogene
NGNE
$284M
$2.25M 0.35%
15,000
SCTL
52
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2M 0.31%
780,500
CLRB icon
53
Cellectar Biosciences
CLRB
$15.3M
$1.64M 0.25%
18
AKTX
54
Akari Therapeutics
AKTX
$21.4M
$1.44M 0.22%
1,500
+277
+23% +$266K
BLCM
55
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.38M 0.21%
+6,000
New +$1.38M
AKBA icon
56
Akebia Therapeutics
AKBA
$827M
$1.37M 0.21%
118,000
-282,000
-71% -$3.28M
AGTC
57
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.27M 0.2%
60,600
GALT icon
58
Galectin Therapeutics
GALT
$288M
$1.08M 0.17%
312,000
-138,400
-31% -$480K
NERV icon
59
Minerva Neurosciences
NERV
$16.8M
$1.05M 0.16%
21,875
SCYX icon
60
SCYNEXIS
SCYX
$35.2M
$998K 0.15%
10,000
VCYT icon
61
Veracyte
VCYT
$2.41B
$968K 0.15%
+100,200
New +$968K
AGRX
62
DELISTED
Agile Therapeutics, Inc
AGRX
$921K 0.14%
75
CRIS icon
63
Curis
CRIS
$21.5M
$900K 0.14%
6,000
PTCT icon
64
PTC Therapeutics
PTCT
$4.41B
$518K 0.08%
10,000
-115,000
-92% -$5.96M
EPRS
65
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$425K 0.07%
+75,000
New +$425K
NVRO
66
DELISTED
NEVRO CORP.
NVRO
$387K 0.06%
+10,000
New +$387K
SAGE
67
DELISTED
Sage Therapeutics
SAGE
$37K 0.01%
1,000
-9,000
-90% -$333K
AGIO icon
68
Agios Pharmaceuticals
AGIO
$2.36B
-100,000
Closed -$6.14M
ZSPH
69
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
-50,000
Closed -$1.96M
ALNY icon
70
Alnylam Pharmaceuticals
ALNY
$58.6B
-50,000
Closed -$3.91M
ARWR icon
71
Arrowhead Research
ARWR
$3.84B
-900,000
Closed -$13.3M
JAZZ icon
72
Jazz Pharmaceuticals
JAZZ
$7.99B
-100,000
Closed -$16.1M
CLVS
73
DELISTED
Clovis Oncology, Inc.
CLVS
-70,000
Closed -$3.18M